Custom Manufacturing, Project Outsourcing, your Trusted Partner from China
Severe obesity remains a significant public health challenge, with a pressing need for more effective and widely accessible pharmacological interventions. Amidst ongoing research, Cagrilintide has emerged as a particularly promising candidate, with its development being closely monitored in advanced clinical trials. As a novel long-acting amylin analog obesity treatment, Cagrilintide offers a unique mechanism of action, acting as a dual agonist on amylin receptors (AMYR) and calcitonin G protein-coupled receptors (CTR). This distinct approach is proving instrumental in inducing significant and sustained weight loss, even in individuals with severe obesity.
The results from the CagriSema clinical trial results, particularly those involving the Cagrilintide semaglutide combination for obesity, have been especially compelling. These trials demonstrated superior weight reduction and improvements in cardiometabolic parameters compared to single-agent therapies or placebo. Such robust outcomes underscore Cagrilintide’s potential to bridge the efficacy gap between existing medications and bariatric surgery, offering a powerful new tool for clinicians. For pharmaceutical manufacturers and researchers, the ability to buy Cagrilintide powder CAS 1415456-99-3 from a reliable Cagrilintide supplier is essential for facilitating these critical trials and bringing future drugs to market. NINGBO INNO PHARMCHEM CO.,LTD. proudly supports these advancements by providing high-quality raw materials.
Beyond its efficacy, the tolerability and safety profile observed for Cagrilintide, both as monotherapy and in combination, are crucial for its long-term application in severe obesity management. The ongoing Phase 3 trials, such as REDEFINE, are further solidifying its position as a potential cornerstone therapy. As the scientific community awaits final regulatory approvals, the focus shifts to ensuring that high-purity raw materials are readily available globally. NINGBO INNO PHARMCHEM CO.,LTD. is committed to being a consistent Cagrilintide manufacturer, contributing to the development and accessibility of these vital future drugs for severe obesity.
Manufacturing Facilities
Professional Export Experience
to Global Customers
1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;
2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;
3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).
A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.
A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.
A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.
